SIGN UP

top stories

Drugmakers stockpile inventory in the US, seeking to get ahead of Trump tariffs

3 hours ago

Regeneron to boost its US manufacturing through a $3B Fujifilm deal

6 minutes ago

Exclusive: George Church startup will study long-lived animals, humans to find life-extending genes

2 hours ago

Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout

1 hour ago

Latest

Most read

As the XBI suffers, Q1 shows a few comforting signs of underlying stability

6 hours ago

Insurers have a Medicare Advantage problem

2 hours ago

Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms

2 hours ago

Preventive health startup Superpower raises $30M

4 hours ago

Updated: Roche’s $50B US investment includes previous build announcements

6 hours ago

AstraZeneca, Daiichi eye first-line breast cancer market after Enhertu's early Phase 3 win

7 hours ago

see latest stream

People

Roivant brings rare disease program closer as Immunovant CEO retires

Yesterday

Exclusive: Charm Therapeutics' founder steps down as CEO, as AI biotech eyes clinic in 2026

5 days ago

Mural Oncology ends clinical development, lays off most workers

Last week

Financing

Netherlands pours $1.5B into biotech in pursuit of global leadership ambitions

5 days ago

Exclusive: BigHat inks Lilly deal for AI-boosted antibodies, extends Series B

5 days ago

Biotech seed rounds sink to lowest level in years as industry slump drags on

6 days ago

Startups

China startup injects CRISPR therapy into the brain for the first time

Yesterday

Exclusive: VelaVigo inks another US biotech deal as China drug development scene booms

4 days ago

Glycomine raises $115M to see if it can treat rare glycosylation disorder

6 days ago

Deals

Sanofi to pay $125M upfront for two immunology drugs from little-known biotech

5 days ago

Ayrmid misses deadline for detailed offer to top private equity bid for bluebird

6 days ago

GeneDx to buy Fabric Genomics for up to $51M

6 days ago

In FocusSee all

Primate researchers cope with uncertainty as NIH appeals for payment cuts in court

Last week

‘People will die’: End of NIH grants guts work between academics and companies to counter next pandemic

4 weeks ago

Illumina was built on DNA. Its future could be biology’s next big wave

Last month

A California health tech company is letting AI run medical visits, from intake to diagnosis

Last month

Endpoints Standouts

How the world's biggest pharma and biotech companies paid their typical worker in 2023

9 months ago

In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024

9 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

10 months ago

Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?

10 months ago

Peer review See all

Apr

17

Sarepta loses CMO to RNA editing upstart; Another wave of personnel moves at Dyne

Apr

11

Ira Mellman joins PICI; ViiV Healthcare CMO replaces Chris Corsico at GSK

Apr

4

Novo Nordisk adjusts its leadership team; Dyne alums migrate to Crescent Biopharma

Mar

28

On the heels of staff cuts, CRISPR Therapeutics COO departs; Changes galore at Bicycle

Mar

21

BridgeBio, Editas finance chiefs depart; Former FDA No. 2 joins Recursion's board

Pharma channel feed

Yesterday

Alvogen unit appeals court loss shielding Bausch Health's IBS drug from generics

Alvogen plans to fight a court decision that could significantly delay its ability to bring a generic version of Bausch Health's Xifaxan to market, the company said.

READ MORE

GSK kicks off Blenrep relaunch plans with clearance from UK regulators

5 days ago

CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

5 days ago

latest in Pharma

US drugs rely heavily on ingredients made overseas, new report shows

5 days ago

Pharma's wins and losses in Trump's sprawling executive order on drug prices

5 days ago

Biotechs start to disclose tariff exposure with US trade inquiry underway

6 days ago

At ACIP hearing, CDC says it's 'scraping' to respond to measles outbreak; FDA comments on Novavax halt

6 days ago

Trump pledges his support for a change to the IRA long sought by drugmakers

6 days ago

see latest stories

Marketing channel feed

2 weeks ago

HHS says it may revisit anti-obesity drug policies after dropping Biden-era proposal

The government said it “may consider future policy options” for anti-obesity medications, after declining to finalize a Biden-era proposal that would have expanded coverage to millions ...

READ MORE

RFK Jr. has long criticized drug ads. He just slashed the FDA office that regulates them

3 weeks ago

J&J touts new survival data pitting lung cancer combo against AstraZeneca's rival

4 weeks ago

latest in Marketing

Novo Nordisk slashes Wegovy price by nearly two-thirds for cash-paying patients

Last month

Misleading exhibit booth panel lands NJ drugmaker an untitled letter from FDA

Last month

Eli Lilly expands Zepbound single-dose vial options at lower price

Last month

J&J's new cancer combo beats AstraZeneca's Tagrisso on survival in lung trial

3 months ago

Drugs are approved — and made available — faster in US than most of EU, data show

4 months ago

see latest stories

FDA+ channel feed

22 hours ago

FDA plans to ban pharma employees from serving on adcomms. The impact will be limited

The FDA is looking to further limit pharma companies' involvement in advisory committees that typically review new drugs or safety issues. But the shift away from pharma influence is likely ...

READ MORE

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

Yesterday

FDA approves Dupixent for hives, rejects new Eylea dosing schedule

Yesterday

latest in FDA+

Click gets FDA authorization for preventive migraine digital therapeutic

6 days ago

Leqembi wins EU authorization for some Alzheimer's patients, giving Biogen, Eisai a boost over Lilly

6 days ago

CDC vaccine advisors are set to meet this week after two-month delay and scrutiny from Kennedy

Last week

AbbVie and Sandoz agree to drop court spat over Rinvoq patents

Last week

FDA's union readies negotiations with HHS over some fired staff

Last week

see latest stories

Manufacturing channel feed

5 days ago

Bayer opens $44M US expansion; Meribel CDMO launches in Europe

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and more.

READ MORE

J&J's Duato says 'not tariffs, but tax policy' is best way to boost US manufacturing

6 days ago

Pharma tariffs could leave little room to hide with sweeping probe underway

Last week

latest in Manufacturing

Trump pharma tariffs inch closer as administration confirms US trade probe

Last week

Pharma tariffs to arrive 'in the next month or two,' commerce secretary says

Last week

CDMOs anticipate inspection bottlenecks after mass FDA firings

Last week

Novartis follows Lilly and J&J in announcing multibillion-dollar US manufacturing investment

Last week

Pharma tariffs: Here’s what a potential rollout could look like

Last week

see latest stories